Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Narazaciclib by Traws Pharma for Endometrial Cancer: Likelihood of Approval
Narazaciclib is under clinical development by Traws Pharma and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...
Narazaciclib by Traws Pharma for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Narazaciclib is under clinical development by Traws Pharma and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
Narazaciclib by Traws Pharma for Colorectal Cancer: Likelihood of Approval
Narazaciclib is under clinical development by Traws Pharma and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...